Albireo receives european marketing authorization of bylvay™ (odevixibat), the first drug treatment for progressive familial intrahepatic cholestasis (pfic)

– first approval in the world of bylvay for the treatment of pfic –
ALBO Ratings Summary
ALBO Quant Ranking